Tenax Therapeutics, Inc. · NASDAQ:TENX
Morgan Stanley reported a 9.60% stake in Tenax Therapeutics, Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 12, 2026
Morgan Stanley reported a 9.60% stake in Tenax Therapeutics, Inc., 596,376 shares, as a passive investor on Dec 31, 2025. Filed Feb 12, 2026 (Schedule 13G).
- Stake
- 9.60%
- Shares
- 596,376
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 9.60% | 596,376 |
| Morgan Stanley Capital Services LLC | 9.50% | 592,316 |
Source
Related
- Tenax Therapeutics, Inc.
- Morgan Stanley
- Tenax Therapeutics, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Apr 8, 2026
- Form 4 · ADAR1 Capital Management, LLC · Oct 21, 2026
- Schedule 13G/A · Millennium Management LLC · Oct 15, 2026
- Schedule 13G/A · Sphera Funds Management LTD. · Oct 13, 2026
- Schedule 13G/A · Dellora Investments LP · Oct 9, 2026
- Form 4 · Doogan Declan · Sep 17, 2026